secwatch / observer
8-K filed October 4, 2023, 7:59 PM ET CIK 0001603756
leadership confidence high sentiment neutral materiality 0.55

Axonics CFO Dan Dearen retires; appoints Kari Keese as CFO with new employment agreement

Axonics, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kari Keese

Chief Financial Officer
Axonics, Inc.
Effective
2023-10-02
Filed
October 4, 2023, 7:59 PM ET
the Company has appointed Kari Keese to serve as Chief Financial Officer (Principal Financial and Accounting Officer) of the Company effective upon Mr. Dearen’s exit.
Departed

Dan L. Dearen

President and Chief Financial Officer
Axonics, Inc.
Effective
2023-10-02
Successor
Kari Keese
Filed
October 4, 2023, 7:59 PM ET
Dan L. Dearen, President and Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, will retire from the Company effective October 2, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kari Keese was appointed as Chief Financial Officer at Axonics, Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
the Company has appointed Kari Keese to serve as Chief Financial Officer (Principal Financial and Accounting Officer) of the Company effective upon Mr. Dearen’s exit.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dan L. Dearen retired as President and Chief Financial Officer at Axonics, Inc..

Action
retired
Role
President and Chief Financial Officer
Exact text from the filing
Dan L. Dearen, President and Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, will retire from the Company effective October 2, 2023
View on SEC.gov
Source: SEC EDGAR
accession 0001603756-23-000066
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.